Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Uterine transplantation in an era of successful childbirths from living and deceased donor uteri: Current challenges

R. Chmel, Z. Pastor, J. Matecha, L. Janousek, M. Novackova, J. Fronek

. 2020 ; 164 (1) : 115-120. [pub] 20190523

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21006945

BACKGROUND AND AIMS: Uterine transplantation (UTx) is an experimental sterility treatment method in women with absolute uterine factor infertility. This article describes the current trends and risks in UTx and provides an overview of our experience with this method, to date. METHODS: Based on our experience with the Czech UTx trial and the published results of other trials, we describe the possibilities and risks of this perspective method in the treatment of absolute uterine factor infertility (AUFI). RESULTS: Twelve healthy babies were born in 2014-2018 after more than 40 uterine transplantations. There is no general consensus whether it is more suitable to transplant uteri from living or deceased donors, and nulliparous or parous women (with proven obstetrical functionality). Most centers prefer to collect at least ten frozen embryos from in vitro fertilization (IVF) cycles before transplantation. The serious complication of a surgically successful uterine transplantation is posttransplant partial stenosis of the uterine-vaginal anastomosis that may be a technical problem for embryo transfer, outflow of menstrual blood, and sexual satisfaction due to the narrowed and shortened vagina. This paper concludes that, currently, procurement of the uterus and the transplant procedure are surgically feasible and that none of the transplanted uteri have been lost due to rejection but only because of graft thrombosis or infection. CONCLUSION: Uterine transplantation, after optimization of surgical methods, selection of suitable donors, standardization of immunosuppressive therapy, adjustment of assisted reproductive technologies and obstetrical proceedings might be an effective therapeutic method for women with AUFI who wish to have their own biological child.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21006945
003      
CZ-PrNML
005      
20210503123842.0
007      
ta
008      
210309s2020 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2019.020 $2 doi
035    __
$a (PubMed)31132074
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Chmel, Roman, $d 1964- $7 xx0000099 $u Department of Obstetrics and Gynecology, 2 nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
245    10
$a Uterine transplantation in an era of successful childbirths from living and deceased donor uteri: Current challenges / $c R. Chmel, Z. Pastor, J. Matecha, L. Janousek, M. Novackova, J. Fronek
504    __
$a Literatura
520    9_
$a BACKGROUND AND AIMS: Uterine transplantation (UTx) is an experimental sterility treatment method in women with absolute uterine factor infertility. This article describes the current trends and risks in UTx and provides an overview of our experience with this method, to date. METHODS: Based on our experience with the Czech UTx trial and the published results of other trials, we describe the possibilities and risks of this perspective method in the treatment of absolute uterine factor infertility (AUFI). RESULTS: Twelve healthy babies were born in 2014-2018 after more than 40 uterine transplantations. There is no general consensus whether it is more suitable to transplant uteri from living or deceased donors, and nulliparous or parous women (with proven obstetrical functionality). Most centers prefer to collect at least ten frozen embryos from in vitro fertilization (IVF) cycles before transplantation. The serious complication of a surgically successful uterine transplantation is posttransplant partial stenosis of the uterine-vaginal anastomosis that may be a technical problem for embryo transfer, outflow of menstrual blood, and sexual satisfaction due to the narrowed and shortened vagina. This paper concludes that, currently, procurement of the uterus and the transplant procedure are surgically feasible and that none of the transplanted uteri have been lost due to rejection but only because of graft thrombosis or infection. CONCLUSION: Uterine transplantation, after optimization of surgical methods, selection of suitable donors, standardization of immunosuppressive therapy, adjustment of assisted reproductive technologies and obstetrical proceedings might be an effective therapeutic method for women with AUFI who wish to have their own biological child.
650    12
$a výběr dárců $7 D046148
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a ženská infertilita $x chirurgie $7 D007247
650    _2
$a těhotenství $7 D011247
650    _2
$a výsledek těhotenství $7 D011256
650    12
$a asistovaná reprodukce $7 D027724
650    _2
$a uterus $x transplantace $7 D014599
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pastor, Zlatko, $d 1960- $7 xx0052265 $u Department of Obstetrics and Gynecology, 2 nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Matěcha, Jan $7 xx0237885 $u Department of Obstetrics and Gynecology, 2 nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic; Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Janoušek, Libor, $d 1970- $7 mzk2008469231 $u Transplantation Surgery Department, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Nováčková, Marta $7 xx0079426 $u Department of Obstetrics and Gynecology, 2 nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Froněk, Jiří, $d 1970- $7 xx0061406 $u Transplantation Surgery Department, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 1 (2020), s. 115-120
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31132074 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20210309 $b ABA008
991    __
$a 20210408181915 $b ABA008
999    __
$a ok $b bmc $g 1648167 $s 1127283
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 164 $c 1 $d 115-120 $e 20190523 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20210309

Find record

Citation metrics

Archiving options